Clinical Trials on Glabellar Crease
Total 10000 results
-
Fudan UniversityRecruiting
-
Beijing 302 HospitalRecruitingTNBC - Triple-Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Triple-Negative Breast CancerChina
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Karolinska University HospitalTerminatedMetastatic Triple-Negative Breast CarcinomaSweden
-
Mridula George, MDActive, not recruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., LtdCompletedTriple Negative Breast Cancer (TNBC)China
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoCompletedMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Veru Inc.WithdrawnMetastatic Triple Negative Breast Cancer
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownTriple Negative Breast Cancer (TNBC)China
-
City of Hope Medical CenterCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
University of WashingtonKuni FoundationRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Mayo ClinicRecruitingMetastatic Breast Cancer | Anatomic Stage IV Breast Cancer AJCC v8 | Estrogen-receptor-positive Breast Cancer | Metastatic HER2-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnBreast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Metastatic Breast Carcinoma | Female Breast Cancer
-
Kristina A. FanucciJohns Hopkins University; Translational Breast Cancer Research Consortium; Menarini... and other collaboratorsRecruitingBreast Cancer | Breast Neoplasms | Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen-receptor-positive Breast Cancer | ESR1 Gene Mutation | Hormone Receptor Positive Breast Cancer | HER2- Breast Cancer | ER WildtypeUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer StageUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyTerminatedUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Avelas Biosciences, Inc.Clinipace Worldwide; RRD International, Inc.CompletedStage I Breast Cancer | Stage II Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer Female | Stage III Breast Cancer | Carcinoma Breast | Primary Invasive Malignant Neoplasm of Female BreastUnited States
-
Ohio State University Comprehensive Cancer CenterAmerican Institute for Cancer ResearchRecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Triple-Negative Breast CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Universitas AirlanggaNot yet recruitingBreast Cancer | Breast Neoplasm Female | Locally Advanced Breast Cancer | Locally Advanced Breast Cancer (LABC)
-
Peking University People's HospitalNot yet recruitingHER2-negative Breast Cancer | Hormone Receptor-Positive Breast Cancer | Early-Stage Breast Cancer | ctDNA Monitoring | High-risk Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNeoadjuvant Therapy | Triple-Negative Breast Cancer (TNBC)China
-
Ana C Garrido-Castro, MDAstraZeneca; Translational Breast Cancer Research ConsortiumRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | HER2-low Breast CancerUnited States
-
Baylor Research InstituteRecruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States
-
The Netherlands Cancer InstituteNot yet recruitingAvoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (ASICS)Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Sentinel Lymph Node
-
Kathy MillerPfizer; Astex Pharmaceuticals, Inc.; Van Andel Institute Stand Up to Cancer TeamCompletedMetastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Consorzio OncotechActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene MutationItaly
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Federico II UniversityNot yet recruitingBreast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Cancer
-
University of California, San FranciscoNot yet recruitingBreast Cancer | Metastatic Breast Cancer | Carcinoma of the BreastUnited States
-
Xijing HospitalRecruitingBreast Cancer (Early Breast Cancer)China
-
DOF Inc.Active, not recruitingBreast Reconstruction | Breast Cancer FemaleSouth Korea
-
Georgetown UniversityKaiser PermanenteCompletedBreast Cancer Female | Breast DensityUnited States
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Breast Carcinoma | Breast Cancer FemaleUnited States
-
European Institute of OncologyActive, not recruitingBreast Cancer, Metastatic Breast CancerItaly
-
Washington University School of MedicinePfizer; Rising Tide FoundationTerminatedBreast Cancer | Breast Carcinoma | Cancer of BreastUnited States
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastJapan
-
Hoffmann-La RocheCompletedBreast Cancer, Early Breast CancerSerbia
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastUnited States
-
GlaxoSmithKlineTerminatedNeoplasms, Breast | Relapsed Breast CancerUnited States